http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1274473-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc54b3d034bf3ca14bf9a0f18c492a51
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-95
filingDate 1985-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1990-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29b57c33accd1c311ead5bef2ed1ca49
publicationDate 1990-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1274473-A
titleOfInvention Process for the preparation of pharmaceutical compositions having hypolidemic properties
abstract PRECISION OF DISCLOSURE The invention relates to a new process for obtaining pharmaceutical compositions. It specifically relates to a preparation process of pharmaceutical compositions characterized in that one in-body or mix a therapeutically-active amount an Indane dione derivative of formula to one or more inert non-toxic excipients or vehicles pharmaceutically acceptable. The compositions according to the invention contain from 50 to 200 mg active ingredient per intake unit.
priorityDate 1985-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421211821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415823668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415873383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412478856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514014
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8R1I2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24393
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11815
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487501
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID39473
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63153
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y4Z0
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63152
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123358
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31886
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID39473
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07492
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID452829
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PS30
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID198533
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID452829
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ863C3
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10219583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552862
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2796
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280793

Total number of triples: 52.